ClinicalTrials.gg
RecruitingNCT07791472DELIGHT-PUpdated Aug 28, 2026

DElirium and LIGHT: Exploring Modifiable Risk Factors of Delirium - a Pilot Study

An observational study in Circadian Rhythm Disruption and Delirium, sponsored by King's College Hospital NHS Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-08-28.

Sponsored by King's College Hospital NHS Trust · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
10
Ages
50 Years and older
Sex
All
01

Study summary

After a period of critical illness many people develop problems with memory, attention and thinking and this can make daily life more difficult. A risk factor for these problems is delirium. Delirium is a sudden change in the brain that causes confusion and difficulty focusing. People develop delirium when they are sick for another reason, such as a severe infection, or after surgery. Other risk factors for delirium are altered sleep/wake cycle, and absence of daylight. While delirium is very common in critical care, it's difficult to recognise and the reasons why it happens are not fully understood.

There are no treatments for delirium. Management focusses on reducing the impact of things that make it more likely for someone to develop delirium. For example, by making sure pain is well controlled and that family members can visit. While it comes with its challenges, maintaining a normal day and night cycle by turning lights off and reducing the number of interruptions during nighttime hours is also a strategy used and research has shown that sometimes this works. Unfortunately, the findings are not the same in every study, and the reasons why these interventions work to reduce delirium are not explored.

This study, called DELIGHT-P, wants to look at the relationship between delirium and light exposure to help to understand why absence of daylight is a risk factor for delirium. We think it has something to do with changes in the 'body clock' of patients in critical care. To find this out we will collect blood samples, measure light levels at the bedside, and assess participants for delirium. After discharge from critical care we will see participants again and ask them about their memory and do some thinking tests. We will also do another blood test. The blood samples will be tested for markers of changes to the 'body clock' and others will be tested for proteins that might be useful for recognising when someone has delirium.

As this is a pilot study, the research will be done with fewer people taking part. This is to check that the things we want to measure are the right things, and that it's possible to do the research. We hope that in the future we can do a larger study to be able to draw conclusions about what we find. The findings from this study may help us understand how light exposure and an altered body clock contributes to developing delirium. By checking for proteins that might be present in patients who have delirium, it might help us understand what processes are happening in the body to cause delirium. It is possible that through this work, we can identify potential treatment targets for delirium.

We hope that by doing this, we may be able to improve some of the memory and thinking problems that people have after a stay in critical care.

Read the detailed description

Background:

Delirium is a neuropsychiatric syndrome characterised by acute deficits in attention and other aspects of cognition. Patients with delirium have altered arousal, often displaying signs of hypervigilance and agitation, or indeed reduced levels of consciousness that look like coma. Many experience troubling symptoms in the form of hallucinations or delusions. Delirium is associated with longer hospital stays, increased mortality and long term cognitive impairment.

Delirium is highly prevalent in acute hospital environments. In critical care, it is reported that up to 70% of patients have delirium. Despite this, the mechanisms underpinning its onset and persistence are poorly understood. Recent evidence suggests that disruption in circadian rhythms - through altered light exposure, noise and sleep disturbance - may play a role in it's pathophysiology. There have been few studies which have directly measured light intensity and quality within clinical settings and correlated this to markers of circadian disruption and explored how this interacts with delirium risk.

In recent years, markers of neuronal damage have shown promise in helping to detect delirium, and understand the pathophysiological mechanisms underpinning it, but more work is needed to explore their use in critically ill patients at risk of delirium.

DELIGHT-P (DElirium and LIGHT: Exploring modifiable risk factors and mechanisms of delirium - A Pilot Study) is a pilot for a prospective observational cohort study. This observational cohort study will describe patterns of light exposure, endocrine rhythms, and delirium incidence in critically ill patients.

Results from this programme of work will inform the design of a powered observational study and potentially future studies examining whether circadian based interventions can reduce delirium incidence and improve outcomes. Beyond the critical care environment, the findings will support specialties across the NHS where delirium is highly prevalent, as well as guide hospital and critical care design, informing evidence-based policies on light exposure and sleep promoting care.

Importantly, findings from this work may also elucidate some of the mechanisms of delirium, offering insight to what is currently a very challenging syndrome with significant consequences.

Primary Objective:

To assess the feasibility of carrying out a study that exploring modifiable risk factors of delirium. To do this we will assess the recruitment capability, retention rate and evaluate the data collection procedures.

Secondary Objectives

  • To explore the relationship between light exposure, altered circadian rhythms and delirium in critically ill patients.
  • To explore the association between serum markers of inflammation, neuronal damage and delirium
  • To explore the cognitive outcomes of critically ill patients and the relationship with markers of neuronal damage.
02

Conditions studied

  • Circadian Rhythm Disruption
  • Delirium

Browse trials for

03

In context

Delirium

933 studies on the registry are indexed under Delirium; 190 are open to participants now.

This study's planned enrollment of 10 is below the median of 194 across 342 observational studies indexed under Delirium.

Browse Delirium studies →

Lead sponsor

King's College Hospital NHS Trust is the lead sponsor of 171 studies on the registry; 56 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients in critical care

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients >50 years old
  • Patients admitted to critical care in previous 24 hours
  • Patients with an arterial or venous access line suitable for blood sampling
  • Patients with an expected length of stay >36 hours

Exclusion criteria

Exclusion Criteria:

  • Patients with a primary neurosurgical diagnosis
  • Patients with pre-existing cognitive impairment
  • Patients expected to die within 24 hours or receiving end of life treatment
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
10 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients in critical care

    Patients receiving care in critical care

06

What researchers measure

Primary outcomes

  1. Recruitment and retention

    Time frame: 6 months

  2. Adherence to study procedures

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07791472
Responsible party
Sponsor
First posted
Aug 28, 2026
Start date
Aug 2026 (estimated)
Primary completion
Feb 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Aug 28, 2026
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion